Information for Healthcare Professionals

Sign up for our newsletter to learn about important information and resources for healthcare and research professionals who serve the hereditary cancer community.

FORCE supports healthcare professionals

If you're a healthcare professional caring for individuals and families affected by hereditary cancer, FORCE has evidence-informed tools, education and support resources to facilitate shared decision-making, and compassionate, informed care to help.

Help Your Patients Find Support

FORCE support programs include virtual community meetings, trained guidance from peer navigators and community message boards. We offer your patients multiple ways to connect with others in a safe, supportive environment. Download our flyer with all our support programs.

Support Meetings & Events

FORCE's Support Meetings and Events Calendar provides details on upcoming support meetings, webinars and partner events. 

View Calendar

1 to 1 Support & Navigation

FORCE's Peer Navigation Program connects those seeking support with a trained peer navigator who shares a similar experience.  

Learn More

Spotlight

ABFM Performance Improvement Module  ›

This module is open to board-certified family medicine doctors. Click on the title or log in to your MyABFM Portal and search for "Improving Assessment and Management of Hereditary Breast and Gynecologic Cancer."

Looking for the latest guidelines?

FORCE provides gene-specific summaries on cancer risk, screening, prevention and treatment guidelines, and resources for individuals with inherited cancer risk. 

Customizable Resources

Add your logo and contact info to FORCE materials

FORCE’s resource center allows you to personalize FORCE publications and genetic test result disclosure letters with your contact information and logo for printing or sharing on demand. We also provide links and QR codes to curated content for specific genes, which you can use within your own materials.

Learn More

Insurance Coverage & Appeals

Find information on insurance coverage and reimbursement for health insurance appeals. Our customizable insurance appeal letters are designed to help you and your patients quickly appeal insurance denials.

Learn More

Find Research Studies Enrolling People with Inherited Mutations

Use our search and enroll tool to connect your patients to the latest cancer prevention, treatment and quality-of-life studies enrolling people with or at high risk for hereditary cancers. 

Testing an Acupressure App for Cancer Survivors with Fatigue and Sleep Problems

This clinical trial is testing whether using acupressure guided by the EnergyPoints App can reduce cancer-related fatigue and improve sleep in adult cancer survivors residing in the U.S.

Comparing Daraxonrasib With or Without Chemotherapy to Chemotherapy Alone for First-Line Treatment of Metastatic Pancreatic Cancer (Rasolute 303)

This study is testing a new targeted drug called daraxonrasib to see if it helps people with metastatic pancreatic cancer live longer or keep their cancer from growing longer than standard chemotherapy alone. Researchers are...

A Study to Learn About the Study Medicine Called PF-07248144 in Combination with Fulvestrant in People with HR-positive, HER2-negative Advanced or Metastatic Breast Cancer who Progressed After a Prior Line of Treatment

This study is for adults with advanced/metastatic HR-positive, HER2-negative advanced or metastatic breast cancer who have previously been treated with a CDK4/6 inhibitor and have received two or less treatments for their advanced metastatic breast...

Go Behind the Headlines

Force's XRAY program shares easy-to-understand information on the latest cancer research.

Study : Combination maintenance therapy may benefit some people with metastatic pancreatic cancer

The phase 2 POLAR trial tested maintenance therapy with Keytruda (pembrolizumab) and Lynparza (olaparib) in metastatic pancreatic cancer patients whose disease had not worsened after platinum-based chemotherapy. Maintenance therapy is treatment given after initial treatment...

Update : What people with breast implants should know about rare cancers and other safety concerns

Breast implants are used for reconstruction after mastectomy and for cosmetic enlargement of the breasts. Most people with implants do not develop serious problems. However, rare cancers may develop in the scar tissue around breast...

Study : Mutations in familial melanoma genes and cancer risk

Researchers studied nearly 700,000 people from the United States and the United Kingdom to learn how common mutations in familial melanoma genes are in the general population. They found that these mutations may be more...

Quickly share FORCE resources with just a few clicks!

FORCE’s Healthcare Provider Toolkit makes it easy to distribute resources across your favorite social media platforms.